Alvotech (ALVO) Exchange Rate Effect (2021 - 2026)
Alvotech's (ALVO) quarterly Exchange Rate Effect came in at $1.3 million in Q1 2026, down 83.67% YoY from $7.9 million in Q1 2025, and up 107.75% on a QoQ basis from -$16.7 million in Q4 2025.
Alvotech (ALVO) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Exchange Rate Effect data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Exchange Rate Effect fell 83.67% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 116.17% YoY) and the FY2025 annual result came in at $4.5 million, up 440.71% from the prior year.
- Exchange Rate Effect advanced to $1.3 million in Q1 2026, from -$16.7 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $17.8 million in Q3 2025 to a low of -$16.7 million in Q4 2025.
- A 5-year average of $466170.9 and a median of $825564.0 in 2024 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 2056.47% in 2025, down 1162.46% in 2025.
- Tracing ALVO's Exchange Rate Effect over 5 years: stood at -$113000.0 in 2022, then tumbled by 71.68% to -$194000.0 in 2023, then plunged by 582.47% to -$1.3 million in 2024, then tumbled by 1162.46% to -$16.7 million in 2025, then soared by 107.75% to $1.3 million in 2026.
- The last three Exchange Rate Effect figures came in at $1.3 million (Q1 2026), -$16.7 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -16.72 Mn |
| Dec 31, 2025 | -16.72 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | -4.51 Mn |
| Jun 30, 2025 | -4.51 Mn |
| Mar 31, 2025 | 7.93 Mn |
| Mar 31, 2025 | 7.93 Mn |
| Dec 31, 2024 | -1.32 Mn |
| Dec 31, 2024 | -1.32 Mn |
| Sep 30, 2024 | 825,564.00 |
| Sep 30, 2024 | 825,564.00 |
| Jun 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | -6.53 Mn |
| Mar 31, 2024 | -6.53 Mn |
| Dec 31, 2023 | -194,000.00 |
| Dec 31, 2023 | -194,000.00 |